261 related articles for article (PubMed ID: 21977908)
1. Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome.
Henkhaus RS; Kim SJ; Kimonis VE; Gold JA; Dykens EM; Driscoll DJ; Butler MG
Genet Test Mol Biomarkers; 2012 Mar; 16(3):178-86. PubMed ID: 21977908
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification.
Procter M; Chou LS; Tang W; Jama M; Mao R
Clin Chem; 2006 Jul; 52(7):1276-83. PubMed ID: 16690734
[TBL] [Abstract][Full Text] [Related]
3. [Methylation-specific multiplex ligation-dependent probe amplification in diagnosis of Prader-Willi syndrome and Angelman syndrome].
Li MR; Wang XZ; Liu XY; Yang YL; Bao XH; Zhang YH; Xiong H; Zhong N; Qin J; Wu XR; Pan H
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3257-61. PubMed ID: 19159549
[TBL] [Abstract][Full Text] [Related]
4. Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities.
Bittel DC; Kibiryeva N; Butler MG
Genet Test; 2007; 11(4):467-75. PubMed ID: 18294067
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Methylation-Specific Multiplex Ligation-Dependent Probe Amplification for the Diagnosis of Prader-Willi Syndrome and Angelman Syndrome.
Kim B; Park Y; Cho SI; Kim MJ; Chae JH; Kim JY; Seong MW; Park SS
Ann Lab Med; 2022 Jan; 42(1):79-88. PubMed ID: 34374352
[TBL] [Abstract][Full Text] [Related]
6. [Prader-Willi and Angelman syndromes: case series diagnosed by MS-MLPA assay].
Rios-Flores IM; Bobadilla-Morales L; Peña Padilla C; Corona-Rivera A; Acosta-Fernández E; Santana-Hernández J; Brukman-Jiménez SA; Corona Rivera JR
Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):170-178. PubMed ID: 34232598
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of Prader-Willi syndrome and Angelman syndrome for fetuses with suspicious deletion of chromosomal region 15q11-q13.
Chang CW; Hsu HK; Kao CC; Huang JY; Kuo PL
Int J Gynaecol Obstet; 2014 Apr; 125(1):18-21. PubMed ID: 24434231
[TBL] [Abstract][Full Text] [Related]
8. Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain.
Brant JO; Riva A; Resnick JL; Yang TP
Epigenetics; 2014 Nov; 9(11):1540-56. PubMed ID: 25482058
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes.
Mahmoud R; Singh P; Weiss L; Lakatos A; Oakes M; Hossain W; Butler MG; Kimonis V
Am J Med Genet A; 2019 Jan; 179(1):29-36. PubMed ID: 30556641
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of multiplex ligation-dependent probe amplification assay used for detecting deletion of Prader-Willi syndrome.
Shao H; Lip V; Wu BL
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 37(1):64-7. PubMed ID: 15719045
[TBL] [Abstract][Full Text] [Related]
11. Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects.
Hassan M; Butler MG
Eur J Med Genet; 2016 Nov; 59(11):584-589. PubMed ID: 27659713
[TBL] [Abstract][Full Text] [Related]
12. [Value of methylation-specific mutiplex ligation-dependent probe in the diagnosis of Prader-Willi syndrome].
Zhan SN; Wang CZ; Yang Y; Wang Y; Wu HL; Li H; He XY
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jun; 14(6):445-8. PubMed ID: 22738453
[TBL] [Abstract][Full Text] [Related]
13. Exploring the unique function of imprinting control centers in the PWS/AS-responsible region: finding from array-based methylation analysis in cases with variously sized microdeletions.
Matsubara K; Itoh M; Shimizu K; Saito S; Enomoto K; Nakabayashi K; Hata K; Kurosawa K; Ogata T; Fukami M; Kagami M
Clin Epigenetics; 2019 Feb; 11(1):36. PubMed ID: 30819260
[TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes.
Glenn CC; Driscoll DJ; Yang TP; Nicholls RD
Mol Hum Reprod; 1997 Apr; 3(4):321-32. PubMed ID: 9237260
[TBL] [Abstract][Full Text] [Related]
15. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes.
Kim SJ; Miller JL; Kuipers PJ; German JR; Beaudet AL; Sahoo T; Driscoll DJ
Eur J Hum Genet; 2012 Mar; 20(3):283-90. PubMed ID: 22045295
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation.
Saitoh S; Buiting K; Cassidy SB; Conroy JM; Driscoll DJ; Gabriel JM; Gillessen-Kaesbach G; Glenn CC; Greenswag LR; Horsthemke B; Kondo I; Kuwajima K; Niikawa N; Rogan PK; Schwartz S; Seip J; Williams CA; Nicholls RD
Am J Med Genet; 1997 Jan; 68(2):195-206. PubMed ID: 9028458
[TBL] [Abstract][Full Text] [Related]
17. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
[TBL] [Abstract][Full Text] [Related]
18. PWS/AS MS-MLPA Confirms Maternal Origin of 15q11.2 Microduplication.
Dawson AJ; Cox J; Hovanes K; Spriggs E
Case Rep Genet; 2015; 2015():474097. PubMed ID: 26064710
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader-Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2-q13.
Kim BY; Lee JS; Kim YO; Koo SK; Park MH
Stem Cell Res; 2020 Jul; 46():101847. PubMed ID: 32474395
[TBL] [Abstract][Full Text] [Related]
20. A modified MS-PCR approach to diagnose patients with Prader-Willi and Angelman syndrome.
Dos Santos JF; Mota LR; Rocha PH; Ferreira de Lima RL
Mol Biol Rep; 2016 Nov; 43(11):1221-1225. PubMed ID: 27535666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
